Low-dose hormone therapy in the perimenopause

Int J Gynaecol Obstet. 2007 Aug;98(2):138-42. doi: 10.1016/j.ijgo.2007.04.008. Epub 2007 Jun 18.

Abstract

Objective: To evaluate the effects of low-dose hormone therapy (LD-HT) on bleeding pattern and vasomotor symptoms in perimenopausal women.

Methods: In a prospective, open-label study at an University clinic, 120 perimenopausal women suffering from irregular menstrual cycles and hot flushes were randomized to micronized 17beta-estradiol 1 mg plus dydrogesterone 10 mg sequential added (LD-HT; group A: 60 subjects) or dydrogesterone 10 mg from day 15 to 28 (group B: 60 subjects). Number and severity of hot flushes and bleeding pattern were assessed throughout the study.

Results: Women in group A experienced a significant reduction in number of hot flushes while no significant variation was observed in group B. The incidence of cyclic bleeding was 86% in group A and 76% in group B, the mean duration was significantly lower in group A than in group B.

Conclusions: LD-HT may control both irregular bleeding and hot flushes in perimenopausal women.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Dydrogesterone / administration & dosage*
  • Estradiol / administration & dosage*
  • Female
  • Hormone Replacement Therapy / methods*
  • Hot Flashes / drug therapy*
  • Humans
  • Menorrhagia / drug therapy
  • Middle Aged
  • Perimenopause / drug effects*
  • Progesterone Congeners / administration & dosage*
  • Prospective Studies

Substances

  • Drug Combinations
  • Progesterone Congeners
  • Estradiol
  • Dydrogesterone